The Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery ( SYNTAX ) trial demonstrated that in patients with 3-vessel or left main coronary artery disease , coronary artery bypass graft surgery ( CABG ) was associated with a lower rate of cardiovascular death , myocardial infarction , stroke , or repeat revascularization compared with percutaneous coronary revascularization with drug-eluting stents ( DES-PCI ) ) .